↓ Skip to main content

Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma

Overview of attention for article published in Journal of Hematology & Oncology, October 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
40 Dimensions

Readers on

mendeley
51 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma
Published in
Journal of Hematology & Oncology, October 2012
DOI 10.1186/1756-8722-5-59
Pubmed ID
Authors

Kari Hemminki, Xiangdong Liu, Asta Försti, Jianguang Ji, Jan Sundquist, Kristina Sundquist

Abstract

Patients with many types of autoimmune diseases (AIDs) are at an increased risk of cancer, which may depend on underlying dysregulation of the immune system or treatment. We systematically analyzed myeloma risk and survival in patients diagnosed with 33 different AIDs.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 51 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 24%
Student > Master 10 20%
Researcher 7 14%
Other 4 8%
Student > Bachelor 2 4%
Other 8 16%
Unknown 8 16%
Readers by discipline Count As %
Medicine and Dentistry 23 45%
Pharmacology, Toxicology and Pharmaceutical Science 4 8%
Mathematics 3 6%
Agricultural and Biological Sciences 3 6%
Nursing and Health Professions 2 4%
Other 6 12%
Unknown 10 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 October 2012.
All research outputs
#18,316,001
of 22,679,690 outputs
Outputs from Journal of Hematology & Oncology
#925
of 1,187 outputs
Outputs of similar age
#130,767
of 172,325 outputs
Outputs of similar age from Journal of Hematology & Oncology
#8
of 10 outputs
Altmetric has tracked 22,679,690 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,187 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.4. This one is in the 13th percentile – i.e., 13% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 172,325 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.